205 related articles for article (PubMed ID: 29980871)
1. Classical Hodgkin lymphoma-type and monomorphic-type post-transplant lymphoproliferative disorder following liver transplantation: a case report.
Kumata H; Nakanishi C; Murakami K; Miyagi S; Fukuhara N; Carreras J; Nakamura N; Ichinohasama R; Unno M; Kamei T; Sasano H
Surg Case Rep; 2018 Jul; 4(1):72. PubMed ID: 29980871
[TBL] [Abstract][Full Text] [Related]
2. Three different histological subtypes of Epstein-Barr virus-negative post-transplant lymphoproliferative disorder in a patient with hepatitis C infection.
Kobayashi M; Asano N; Fukushima M; Honda T
Int J Hematol; 2014 Sep; 100(3):307-11. PubMed ID: 24879033
[TBL] [Abstract][Full Text] [Related]
3. A Rare Case of Classical Hodgkin Lymphoma Diagnosed 10 Years after Liver Transplant.
Zhang L; Pereira Mestre R; Bihl F; Bühler M; Vannata B; Stathis A
Case Rep Oncol; 2017; 10(3):923-927. PubMed ID: 29279693
[TBL] [Abstract][Full Text] [Related]
4. Aggressive Epstein-Barr virus-negative B-cell post-transplant lymphoproliferative disorder in a hepatitis C-negative liver transplant recipient who received a hepatitis C-positive graft: Implications for D+/R- hepatitis C virus seroconversion.
Kutzler HL; Collins K; Maneckshana B; Rochon C; Einstein M; Mnayer L; Rezuke WN; Sheiner P; Serrano OK
Transpl Infect Dis; 2019 Oct; 21(5):e13144. PubMed ID: 31291501
[TBL] [Abstract][Full Text] [Related]
5. [Post-transplant lymphoproliferative disorder: a clinicopathologic study of 15 cases].
Chen DB; Wang Y; Song QJ; Shen DH
Zhonghua Bing Li Xue Za Zhi; 2012 Sep; 41(9):607-12. PubMed ID: 23157829
[TBL] [Abstract][Full Text] [Related]
6. Classic Hodgkin lymphoma post-transplant lymphoproliferative disorders (PTLD) are often preceded by discordant PTLD subtypes.
Stubbins RJ; Mabilangan C; Rojas-Vasquez M; Lai RL; Zhu J; Preiksaitis JP; Peters AC
Leuk Lymphoma; 2020 Dec; 61(14):3319-3330. PubMed ID: 32878528
[TBL] [Abstract][Full Text] [Related]
7. Post-transplant lymphoproliferative disorder--case reports of three children with kidney transplant.
Spasojević-Dimitrijeva B; Peco-Antić A; Paripović D; Kruscić D; Krstić Z; Cupić M; Cvetković M; Milosevski-Lomić G; Kostić M
Srp Arh Celok Lek; 2014; 142(1-2):83-8. PubMed ID: 24684038
[TBL] [Abstract][Full Text] [Related]
8. Post-transplant lymphoproliferative disorder after adult-to-adult living donor liver transplant: case series and review of literature.
Kataoka K; Seo S; Sugawara Y; Ota S; Imai Y; Takahashi T; Fukayama M; Kokudo N; Kurokawa M
Leuk Lymphoma; 2010 Aug; 51(8):1494-501. PubMed ID: 20578817
[TBL] [Abstract][Full Text] [Related]
9. [Post-transplant lymphoproliferative disease in liver transplant recipients--Merkur University Hospital single center experience].
Filipec-Kanizaj T; Budimir J; Colić-Cvrlje V; Kardum-Skelin I; Sustercić D; Naumovski-Mihalić S; Mrzljak A; Kolonić SO; Sobocan N; Bradić T; Dolić ZM; Kocman B; Katicić M; Zidovec-Lepej S; Vince A
Acta Med Croatica; 2011 Sep; 65 Suppl 1():37-43. PubMed ID: 23126028
[TBL] [Abstract][Full Text] [Related]
10. Posttransplant lymphoproliferative disorder in pediatric renal transplantation.
Srivastava T; Zwick DL; Rothberg PG; Warady BA
Pediatr Nephrol; 1999 Nov; 13(9):748-54. PubMed ID: 10603113
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and treatment of post-transplantation lymphoproliferative disorder in pediatric heart transplant patients.
Schubert S; Abdul-Khaliq H; Lehmkuhl HB; Yegitbasi M; Reinke P; Kebelmann-Betzig C; Hauptmann K; Gross-Wieltsch U; Hetzer R; Berger F
Pediatr Transplant; 2009 Feb; 13(1):54-62. PubMed ID: 18518912
[TBL] [Abstract][Full Text] [Related]
12. Hodgkin-like posttransplant lymphoproliferative disorder in children: does it differ from posttransplant Hodgkin lymphoma?
Ranganathan S; Webber S; Ahuja S; Jaffe R
Pediatr Dev Pathol; 2004; 7(4):348-60. PubMed ID: 14564542
[TBL] [Abstract][Full Text] [Related]
13. Severe cold agglutinin disease caused by recurrent monomorphic Epstein-Barr virus (EBV)-associated post-transplant lymphoproliferative disorder (PTLD), clonally related to an EBV-negative plasmacytic hyperplasia in a pediatric multivisceral organ transplant recipient.
Brunner B; Kropshofer G; Ellemunter H; Brunner A; Mueller T; Margreiter R; Tzankov A
Pediatr Transplant; 2007 Aug; 11(5):547-51. PubMed ID: 17631026
[TBL] [Abstract][Full Text] [Related]
14. Humanized anti-CD20 monoclonal antibody (Rituximab) treatment for post-transplant lymphoproliferative disorder.
Ganne V; Siddiqi N; Kamaplath B; Chang CC; Cohen EP; Bresnahan BA; Hariharan S
Clin Transplant; 2003 Oct; 17(5):417-22. PubMed ID: 14703923
[TBL] [Abstract][Full Text] [Related]
15. Post-transplant lymphoproliferative disorder in liver recipients: Characteristics, management, and outcome from a single-centre experience with >1000 liver transplantations.
Mumtaz K; Faisal N; Marquez M; Healey A; Lilly LB; Renner EL
Can J Gastroenterol Hepatol; 2015; 29(8):417-22. PubMed ID: 26076399
[TBL] [Abstract][Full Text] [Related]
16. A population-based study of 135 lymphomas after solid organ transplantation: The role of Epstein-Barr virus, hepatitis C and diffuse large B-cell lymphoma subtype in clinical presentation and survival.
Kinch A; Baecklund E; Backlin C; Ekman T; Molin D; Tufveson G; Fernberg P; Sundström C; Pauksens K; Enblad G
Acta Oncol; 2014 May; 53(5):669-79. PubMed ID: 24164103
[TBL] [Abstract][Full Text] [Related]
17. A Case of Epstein-Barr Virus-Associated Leiomyosarcoma Concurrently With Posttransplant Lymphoproliferative Disorders After Renal Transplantation.
Aida N; Ito T; Maruyama M; Saigo K; Akutsu N; Aoyama H; Kitamura H; Kenmochi T
Clin Med Insights Case Rep; 2019; 12():1179547619867330. PubMed ID: 31391783
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus-associated monomorphic post-transplant lymphoproliferative disorder after pediatric kidney transplantation: A case report.
Wang Z; Xu Y; Zhao J; Fu YX
World J Clin Cases; 2021 Jan; 9(2):469-475. PubMed ID: 33521117
[TBL] [Abstract][Full Text] [Related]
19. Complete response to post-transplant lymphoproliferative disorder by surgical resection and rituximab after living-donor liver re-transplantation for recurrent primary sclerosing cholangitis.
Haruki K; Shiba H; Shimada J; Okui N; Iida T; Yanaga K
Clin J Gastroenterol; 2017 Feb; 10(1):47-51. PubMed ID: 27796825
[TBL] [Abstract][Full Text] [Related]
20. Early Onset Post-transplant Lymphoproliferative Disorder Presenting with Diarrhea Post-orthotopic Liver Transplant Treated Successfully with Single Rituximab Agent.
Patek B; Strahotin C
Cureus; 2019 Nov; 11(11):e6200. PubMed ID: 31890402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
